In the present study, we aimed to determine the utility of KIF11 and KIF14 as markers of pancreatic cancer prognosis by analyzing the in-house IHC data and RNA-seq-based publicly available datasets in relation to clinicopathological traits and overall survival. The gene discussed is KIF11; the disease is familial pancreatic carcinoma.